Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about MIRM

Recent news which mentions MIRM

< Previous 1 2 3 Next >
Why Shares of Travere Therapeutics Are Slumping Thursday
Tickers MIRM TVTX
Tags Market News TVTX MIRM
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023
Tickers ATSG AZUL BBW BHC
Tags AZUL HPP LPX
From Benzinga
Analyst Ratings for Mirum Pharmaceuticals
Tickers MIRM
Tags MIRM Market News Analyst Ratings
From Benzinga
Around $4M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Tickers ET MIRM PI
Tags Markets PI Insider Trades
From Benzinga
Where Mirum Pharmaceuticals Stands With Analysts
Tickers MIRM
Tags MIRM Analyst Ratings Market News
From Benzinga
Raymond James Maintains Strong Buy Rating for Mirum Pharmaceuticals: Here's What You Need To Know
Tickers MIRM
Tags Analyst Ratings Market News MIRM
From Benzinga
Microsoft To Rally Around 16%? Here Are 10 Other Analyst Forecasts For Tuesday
Tickers CAMT CASY CE G
Tags Pre/Market Outlook PT Changes LESL
From Benzinga
Travere Therapeutics Offloads Bile Acid Product Portfolio: Says Divestment Strengthens Financial Foundation
Tickers MIRM TVTX
Tags Biotech Small Cap Health Care
From Benzinga
The Latest Analyst Ratings for Mirum Pharmaceuticals
Tickers MIRM
Tags BZI/AAR Benzinga Market News
From Benzinga
Analyst Expectations for Mirum Pharmaceuticals's Future
Tickers MIRM
Tags BZI/AAR Benzinga Analyst Ratings
From Benzinga
Mirum Pharmaceuticals: Q1 Earnings Insights
Tickers MIRM
Tags MIRM BZI/Recaps Earnings
From Benzinga
Why Panbela Therapeutics Shares Are Trading Higher By Around 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Tickers AAL AGLE ARWR BACK
Tags SPNT SNAX News
From Benzinga
American Airlines, Cutera, Mirum Pharmaceuticals And Other Big Stocks Moving Lower On Wednesday
Tickers AAL AUDC CRUS CUTR
Tags PTON AUDC NAAS
From Benzinga
Analyst Expectations for Mirum Pharmaceuticals's Future
Tickers MIRM
Tags Analyst Ratings Market News MIRM
From Benzinga
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
Tickers AMBA CGEN CMRX COHU
Tags CMRX RKLB PRAX
From Benzinga
Mirum Pharmaceuticals Earnings Perspective: Return On Capital Employed
Tickers MIRM
Tags MIRM Earnings BZI/ROCE
From Benzinga
Analyst Expectations for Mirum Pharmaceuticals's Future
Tickers MIRM
Tags MIRM Analyst Ratings Market News
From Benzinga
Earnings Scheduled For March 8, 2023
Tickers ABM ADES ASAN ASRT
Tags QNRX VRA ASAN
From Benzinga
Earnings Preview: Mirum Pharmaceuticals
Tickers MIRM
Tags Benzinga MIRM BZI/EP
From Benzinga
AT&T To Rally Over 15%? Here Are 10 Other Analyst Forecasts For Tuesday
Tickers ALLY ARGX ARHS FIVE
Tags ARGX Benzinga LUV
From Benzinga
Mirum Pharmaceuticals's Return On Capital Employed Insights
Tickers MIRM
Tags Benzinga MIRM Market News
From Benzinga
Europe Approves Mirum Pharma's Drug For Rare Genetic Liver Disease
Tickers MIRM
Tags Benzinga MIRM Market News
From Benzinga
Where Mirum Pharmaceuticals Stands With Analysts
Tickers MIRM
Tags BZI/AAR Benzinga Market News
From Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Tickers ABST ACNT AFRM AGFY
Tags EVO TLS WWW
From Benzinga
Robinhood, MicroStrategy And Other Big Losers From Wednesday
Tickers ABST AFRM ASLE BBD
Tags ZM GME ABST
From Benzinga
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
Tickers ABST ACNT AFRM AGFY
Tags GTLS GSUN DWAC
From Benzinga
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
Tickers AAN ACB ADTN AMV
Tags LMST PEGY DUO
From Benzinga
Analysts Expect Mirum Pharma's Liver Disease Candidate Might Exceed Rival Product's Penetration
Tickers ALBO MIRM
Tags News why it's moving Briefs
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2022
Tickers ANAB APPN ASAN ASLE
Tags BIDU WDAY ANAB
From Benzinga
'It Is Too Sizzling For Me': Why Jim Cramer Isn't Buying This 'Red Hot' Group Of Stocks
Tickers KELYA MIRM NET PEP
Tags Jim Cramer Markets NET
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.